European Atopic Eczema Consensus project 2021

The European Atopic Eczema Consensus Report 2022 is the result of a project EFA ran in 2021-2022. The report is the outcome of the discussions of a Consensus Committee of 15 key opinion leaders from the atopic eczema community. As multidisciplinary experts, they conducted an assessment of the atopic eczema community around the three areas that affect patients the most:

• The physical and emotional burden of AD/E

• The diagnosis and care burden of AD/E
• The financial and economic burden of AD/E

Read the report: Danish, Dutch, English, French, German, Hungarian, Portuguese, Serbian, Slovenian, Spanish, Turkish

Atopic dermatitis advocacy

Since 2017, EFA has been vocal in advocating change for all people living with atopic eczema in Europe. 

Itching for Life, EFA’s Patient Reported Outcome on severe atopic eczema in Europe

One of our most relevant contributions to advocacy for atopic eczema has been the biggest-ever Quality of Life survey on severe atopic eczema, conducted in 2018, a patient reported outcome measurement (PROM) that surveyed almost 1,189 patients from 9 European countries. The resulting report “Itching for Life: Quality of Life and costs for people living with severe atopic eczema in Europe” uncovered the reality of atopic eczema, a chronic inflammatory skin disease affecting 3% of adults and 20% of children in Europe, of which 1 in 5 lives with a severe condition. The results of EFA’s report were a breakthrough report that shed light into the life and economic costs encountered by atopic eczema patients. 

Read the report: Czech, Danish, Dutch, English, French, German, Italian, Spanish, Swedish